Dr. Luis MartĂ-BonmatĂ, PhD, Dr. Angel Alberich, PhD[email protected]Molecular ImagingImaging biomarkers have central role in precision medicineImaging biomarkers can have an impact in clinical practice only if the information they provide answers the clinical problem. Biomarker results must be displayed in an intuitive way, and postprocessing platforms should be implemented, write Dr. Luis MartĂ-BonmatĂ, PhD, and Dr. Angel Alberich.September 27, 2016Page 1 of 1Top StoriesMolecular ImagingF-18 PSMA PET-CT proves clinical value in prostate cancerF-18 prostate-specific membrane antigen (PSMA) PET/CT is having a major impact on patient care and therapy decisions in prostate cancer, but it’s crucial to bear in mind the modality’s diagnostic quirks.Molecular ImagingCombined PET scans predict progression of Alzheimer’sMolecular ImagingPET scans predict outcomes for patients undergoing CAR T-cell therapyMRIMRI-based nomogram provides boost in breast cancerCTCT estimated to cause 5% of new cancer cases